Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shard Capital is a London-based independent investment services platform that provides asset management, wealth management, and corporate capital market services. Established in 2010, the firm operates as a multi-asset manager and broker, offering institutional-grade infrastructure to a diverse client base including private individuals and institutional investors. While not a biotechnology company itself, Shard Capital is a significant participant in the life sciences ecosystem, frequently acting as a broker or investment manager for healthcare and technology firms. The company manages various investment vehicles, such as Venture Capital Trusts (VCTs), which target high-growth opportunities in the medical, scientific, and technology sectors. Shard Capital provides essential capital raising and strategic advisory services, helping growth-stage companies navigate the complexities of public and private markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shard Capital.